Broccoli contains glucosinolates, which break down into bioactive compounds like sulforaphane. These compounds have anti-inflammatory, antioxidant, and potential anti-cancer properties. Studies suggest they may reduce prostate cancer risk by inhibiting cancer cell growth, promoting apoptosis, and detoxifying carcinogens. A 2017 meta-analysis found that higher cruciferous vegetable intake, including broccoli, was linked to a lower risk of prostate cancer (odds ratio ~0.87 for high vs. low intake). Sulforaphane may also suppress androgen receptor activity, relevant to prostate cancer progression.
However, evidence is not conclusive. Some cohort studies show no significant association, and clinical trials are limited. Cooking reduces glucosinolate content, so raw or lightly steamed broccoli maximizes benefits. No specific dosage is established, but 1–2 cups daily is often studied. Always consult a doctor for personalized advice, as diet alone isn’t a cure or prevention guarantee.
